PD 140248

Known as: PD-140248, PD140248 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
PD-140248 is an isomerase inhibitor and topoisomerase II inhibitor under development by Parke-Davis and Co as a potential… (More)
Is this relevant?
1995
1995
PD 138312 and PD 140248 are novel broad-spectrum 7-pyrrolidinyl fluoronaphthyridines with a cyclopropyl or a difluorophenyl… (More)
Is this relevant?
1995
1995
The susceptibilities of 120 clinical isolates of Brucella melitensis and 3 reference strains of the same species to six… (More)
Is this relevant?
1994
1994
The susceptibilities of 123 clinically isolated strains of Xanthomonas maltophilia to six fluoroquinolones (clinafloxacin, PD… (More)
  • table 1
  • table 2
Is this relevant?
1993
1993
PD 138312 and PD 140248 are new quinolones with high in vitro activities against a wide spectrum of bacterial species, notably… (More)
Is this relevant?